Shares of Vitalhub Corp. (TSE:VHI – Get Free Report) have received a consensus recommendation of “Buy” from the seven brokerages that are covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is C$13.14.
VHI has been the subject of several analyst reports. Raymond James Financial dropped their target price on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a research report on Tuesday, March 24th. ATB Cormark Capital Markets dropped their target price on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating for the company in a research report on Tuesday, March 10th. Finally, National Bank Financial dropped their target price on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating for the company in a research report on Wednesday, May 27th.
Check Out Our Latest Research Report on VHI
Vitalhub Trading Up 4.7%
Vitalhub (TSE:VHI – Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The company reported C$0.04 earnings per share (EPS) for the quarter. The business had revenue of C$31.91 million during the quarter. Vitalhub had a return on equity of 2.98% and a net margin of 6.13%. Analysts forecast that Vitalhub will post 0.2296467 EPS for the current year.
Insider Activity at Vitalhub
In other news, Director Anthony Pius Shen bought 7,000 shares of the company’s stock in a transaction dated Monday, March 30th. The stock was bought at an average cost of C$7.11 per share, for a total transaction of C$49,770.00. Following the transaction, the director owned 12,470 shares of the company’s stock, valued at C$88,661.70. This represents a 127.97% increase in their ownership of the stock. Also, Director Francis Nelson Shen bought 439,600 shares of the company’s stock in a transaction dated Tuesday, March 24th. The stock was purchased at an average price of C$7.00 per share, with a total value of C$3,077,200.00. Following the completion of the transaction, the director directly owned 588,300 shares in the company, valued at approximately C$4,118,100. This represents a 295.63% increase in their position. Insiders bought a total of 496,600 shares of company stock valued at $3,476,470 over the last 90 days. Corporate insiders own 18.57% of the company’s stock.
About Vitalhub
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Read More
- Five stocks we like better than Vitalhub
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
